Energy consumption 2025:
Total: 23.582 MWh (+0,3 % vs. 2024)
:focal(1244x1082:1245x1083))
As a medium-sized pharmaceutical company, human health is at the core of our corporate identity and a key focus of our responsible business development. We assess the impact of our actions based on an integrated understanding of health that encompasses mental, physical, social and environmental aspects. As part of our transformation process we implement measures across environmental, social and governance topics and align our activities with internationally recognised sustainability goals.
Total: 23.582 MWh (+0,3 % vs. 2024)
Share of renewable: 99,1 %
Total: 1.284 (+ 8,1 % vs. 2024)
Per employee: 6,74
41.954 tCO2eq
3.287 tCO2eq (-10,7 % vs. 2024)
83 gCO2eq per finished pack (-17 % vs. 2024)
Remote/on-site: 64
Through the fields of action outlined below, our activities contribute to selected United Nations Sustainable Development Goals (SDGs).
:focal())
Full connection of the Iserlohn production site to the district heating network
Start of the electrification of the company-owned vehicle fleet
Further expansion of photovoltaic capacity